Frozen Dessert Brand Celebrates National Ice Cream Month with Limited-Edition Flavors andFree Soft Serve Giveaway NEW YORK, July 1, 2025 /PRNewswire/ — Just in time for National Ice Cream Month, 16 Handles is bringing the heat with a series of flavor launches and a sweet giveaway for National Ice Cream Day. The beloved national frozen dessert brand […]

LOS ANGELES, 1er juillet 2025 /PRNewswire/ — Pendant plus d’une décennie, le logo emblématique de 42 Fast Buds, une feuille de cannabis audacieuse associée au chiffre 42, a été bien plus qu’un simple design. Il s’agissait d’un symbole de rébellion, d’innovation et d’engagement dans le mouvement du cannabis. Mais les temps ont changé, comme le monde

SOFIA, Bulgaria, July 1, 2025 /PRNewswire/ — Fibank (First Investment Bank), the largest Bulgarian-owned bank, is expanding its regional presence by directly offering services in the Republic of Greece. Through the My Fibank mobile application, Greek citizens may now use a range of popular products such as current accounts, term deposits, debit cards and banking packages,

Honor the spirit of Independence Day by rolling up a sleeve to give blood WASHINGTON, July 1, 2025 /PRNewswire/ — In a powerful show of unity and commitment to saving lives, the American Red Cross and the Defense Health Agency’s Armed Services Blood Program (ASBP) have joined forces in a new partnership to fortify the

WASHINGTON, July 1, 2025 /PRNewswire/ — Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic and progressive lung condition that affects between 350,000 and 500,000 adults in the United States. The new campaign aims to educate people living with bronchiectasis about

Combined company named Aebi Schmidt Group Trading on NASDAQ expected to begin July 1, 2025 Shyft common stock delisted from Nasdaq NOVI, Mich., July 1, 2025 /PRNewswire/ –The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft”), the North American leader in specialty vehicle manufacturing, assembly, and upfit for the commercial, retail, and service markets, today announced the

Expert dermatologist panel creates new atopic dermatitis (AD) algorithm (stepped diagnosis and treatment recommendations) emphasizing need for therapeutics that address AD’s intense itch, inflammation, and the AD disease stages of Staphylococcus aureus (Staph) colonization through infection Panel underscores unmet need for topical multi-target therapeutic such as investigational new drug candidate Zabalafin Hydrogel to meet this need